Annual Cash & Cash Equivalents
$56.22 M
+$21.91 M+63.84%
31 December 2023
Summary:
Black Diamond Therapeutics annual cash & cash equivalents is currently $56.22 million, with the most recent change of +$21.91 million (+63.84%) on 31 December 2023. During the last 3 years, it has risen by +$21.62 million (+62.46%). BDTX annual cash & cash equivalents is now -63.65% below its all-time high of $154.67 million, reached on 31 December 2019.BDTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$23.43 M
-$9.39 M-28.61%
30 September 2024
Summary:
Black Diamond Therapeutics quarterly cash and cash equivalents is currently $23.43 million, with the most recent change of -$9.39 million (-28.61%) on 30 September 2024. Over the past year, it has dropped by -$34.55 million (-59.60%). BDTX quarterly cash and cash equivalents is now -93.44% below its all-time high of $357.19 million, reached on 31 March 2020.BDTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BDTX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +63.8% | -59.6% |
| 3 y3 years | +62.5% | -49.7% |
| 5 y5 years | +8.8% | -70.2% |
BDTX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -14.6% | +63.8% | -64.4% | at low |
| 5 y | 5 years | -63.6% | +63.8% | -93.4% | +66.1% |
| alltime | all time | -63.6% | +613.6% | -93.4% | +66.1% |
Black Diamond Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $23.43 M(-28.6%) |
| June 2024 | - | $32.81 M(+29.1%) |
| Mar 2024 | - | $25.42 M(-54.8%) |
| Dec 2023 | $56.22 M(+63.8%) | $56.22 M(-3.0%) |
| Sept 2023 | - | $57.98 M(+38.4%) |
| June 2023 | - | $41.89 M(+7.0%) |
| Mar 2023 | - | $39.14 M(+14.1%) |
| Dec 2022 | $34.31 M(-47.8%) | $34.31 M(-36.4%) |
| Sept 2022 | - | $53.96 M(-3.4%) |
| June 2022 | - | $55.88 M(+3.3%) |
| Mar 2022 | - | $54.08 M(-17.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $65.80 M(+90.1%) | $65.80 M(+41.2%) |
| Sept 2021 | - | $46.60 M(+24.9%) |
| June 2021 | - | $37.32 M(+164.6%) |
| Mar 2021 | - | $14.11 M(-59.2%) |
| Dec 2020 | $34.60 M(-77.6%) | $34.60 M(-38.4%) |
| Sept 2020 | - | $56.20 M(-12.2%) |
| June 2020 | - | $63.98 M(-82.1%) |
| Mar 2020 | - | $357.19 M(+130.9%) |
| Dec 2019 | $154.67 M(+199.4%) | $154.67 M(+96.6%) |
| Sept 2019 | - | $78.66 M(+52.3%) |
| Dec 2018 | $51.66 M(+555.8%) | $51.66 M |
| Dec 2017 | $7.88 M | - |
FAQ
- What is Black Diamond Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics annual cash & cash equivalents year-on-year change?
- What is Black Diamond Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Black Diamond Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of BDTX is $56.22 M
What is the all time high annual cash & cash equivalents for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high annual cash & cash equivalents is $154.67 M
What is Black Diamond Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, BDTX annual cash & cash equivalents has changed by +$21.91 M (+63.84%)
What is Black Diamond Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BDTX is $23.43 M
What is the all time high quarterly cash and cash equivalents for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high quarterly cash and cash equivalents is $357.19 M
What is Black Diamond Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, BDTX quarterly cash and cash equivalents has changed by -$34.55 M (-59.60%)